| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anna Dietrich-Muszalska, Joanna Kolodziejczyk-Czepas, Pawel Nowa. Comparative Study of the Effects of Atypical Antipsychotic Drugs on Plasma and Urine Biomarkers of Oxidative Stress in Schizophrenic Patients. Neuropsychiatric disease and treatment. vol 17. 2021-02-26. PMID:33628026. |
therefore, in the present study, we assessed the ability of six atypical ads (clozapine, olanzapine, quetiapine, risperidone, aripiprazole, and ziprasidone) used in schizophrenia treatment to modulate oxidative damage to different biomolecules such as lipids and proteins. |
2021-02-26 |
2023-08-13 |
Not clear |
| Nishant Sharma, Sangeeta Bhat, Divya Ravi, Pius Ochien. Severe hypothermia, bradycardia and cardiac arrest in association with risperidone. BMJ case reports. vol 13. issue 5. 2021-02-08. PMID:32439747. |
antipsychotic medications, including risperidone, are widely used in the treatment of psychiatric disorders, including schizophrenia. |
2021-02-08 |
2023-08-13 |
Not clear |
| Wenjuan Yu, Lei Lei, Yimin Yu, Yan Li, Yifeng Shen, Huafang L. Model-based analysis of therapeutic efficacy of blonanserin and risperidone in schizophrenia patients and effects on prolactin: A randomized double-blind study. Human psychopharmacology. vol 35. issue 1. 2021-02-05. PMID:31837240. |
model-based analysis of therapeutic efficacy of blonanserin and risperidone in schizophrenia patients and effects on prolactin: a randomized double-blind study. |
2021-02-05 |
2023-08-13 |
Not clear |
| Wenjuan Yu, Lei Lei, Yimin Yu, Yan Li, Yifeng Shen, Huafang L. Model-based analysis of therapeutic efficacy of blonanserin and risperidone in schizophrenia patients and effects on prolactin: A randomized double-blind study. Human psychopharmacology. vol 35. issue 1. 2021-02-05. PMID:31837240. |
this study examined randomized controlled trial data for blonanserin and risperidone in chinese schizophrenia patients (n = 264). |
2021-02-05 |
2023-08-13 |
Not clear |
| Ghassan A Alkharboush, Majid A Alsalama. Risperidone-Induced Acute Laryngeal Dystonia: A Case Report. The American journal of case reports. vol 21. 2021-01-28. PMID:32506071. |
case report a 27-year-old woman with schizophrenia on risperidone presented to our emergency department with a sensation of choking and respiratory distress, mimicking a panic attack. |
2021-01-28 |
2023-08-13 |
Not clear |
| Herbert Y Meltzer, Daniel B Share, Karu Jayathilake, Ronald M Salomon, Myung A Le. Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia. Journal of clinical psychopharmacology. vol 40. issue 3. 2021-01-13. PMID:32332459. |
in addition to clozapine, other atypical antipsychotic drugs pharmacologically similar to clozapine, for example, olanzapine, risperidone, and melperone, are also effective in a similar proportion of treatment-resistant schizophrenia (trs) patients, ~40%. |
2021-01-13 |
2023-08-13 |
Not clear |
| Shaoqiang Han, Benjamin Becker, Xujun Duan, Qian Cui, Fei Xin, Xiaofen Zong, Maolin Hu, Mi Yang, Rong Li, Yangyang Yu, Wei Liao, Xiaogang Chen, Huafu Che. Distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy. Schizophrenia research. vol 215. 2021-01-11. PMID:31759811. |
distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy. |
2021-01-11 |
2023-08-13 |
Not clear |
| Shaoqiang Han, Benjamin Becker, Xujun Duan, Qian Cui, Fei Xin, Xiaofen Zong, Maolin Hu, Mi Yang, Rong Li, Yangyang Yu, Wei Liao, Xiaogang Chen, Huafu Che. Distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy. Schizophrenia research. vol 215. 2021-01-11. PMID:31759811. |
to this end, treatment-naive first-episode schizophrenia patients (n = 41) underwent task-free resting-state fmri assessment before (baseline) and after 8 weeks of risperidone monotherapy (n = 38). |
2021-01-11 |
2023-08-13 |
Not clear |
| Chengcheng Pu, Bingjie Huang, Tianhang Zhou, Zhang Cheng, Yi Wang, Chuan Shi, Xin Y. Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia. Neuropsychiatric disease and treatment. vol 16. 2020-12-31. PMID:33364771. |
to investigate the gender differences in the efficacy and side effects of three frequently used antipsychotic medicines (risperidone, olanzapine, aripiprazole) for patients with first-episode schizophrenia during the first year of treatment. |
2020-12-31 |
2023-08-13 |
Not clear |
| Giuseppe Caruso, Margherita Grasso, Annamaria Fidilio, Fabio Tascedda, Filippo Drago, Filippo Carac. Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia. Pharmaceuticals (Basel, Switzerland). vol 13. issue 12. 2020-12-29. PMID:33322693. |
opposite to haloperidol, second-generation antipsychotics (or atypical antipsychotics) such as risperidone, clozapine, and olanzapine exert a strong antioxidant activity in experimental models of schizophrenia by rescuing the antioxidant system, with an increase in superoxide dismutase and glutathione (gsh) serum levels. |
2020-12-29 |
2023-08-13 |
Not clear |
| Matea Nikolac Perkovic, Marina Sagud, Maja Zivkovic, Suzana Uzun, Gordana Nedic Erjavec, Oliver Kozumplik, Dubravka Svob Strac, Ninoslav Mimica, Alma Mihaljevic Peles, Nela Piva. Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia. Scientific reports. vol 10. issue 1. 2020-12-10. PMID:32572118. |
the study assessed the association of the comt rs4680 and rs4818 polymorphisms with therapeutic response to olanzapine, risperidone, clozapine or other antipsychotic medication after 8 weeks of monotherapy in patients with schizophrenia. |
2020-12-10 |
2023-08-13 |
Not clear |
| Matea Nikolac Perkovic, Marina Sagud, Maja Zivkovic, Suzana Uzun, Gordana Nedic Erjavec, Oliver Kozumplik, Dubravka Svob Strac, Ninoslav Mimica, Alma Mihaljevic Peles, Nela Piva. Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia. Scientific reports. vol 10. issue 1. 2020-12-10. PMID:32572118. |
521 caucasian patients with schizophrenia received a monotherapy with olanzapine (10-20 mg/day; n = 190), risperidone (3-6 mg/day; n = 99), or clozapine (100-500 mg/day; n = 102). |
2020-12-10 |
2023-08-13 |
Not clear |
| Milica M Borovcanin, Slavica Minic Janicijevic, Ivan P Jovanovic, Nevena M Gajovic, Milena M Jurisevic, Nebojsa N Arsenijevi. Type 17 Immune Response Facilitates Progression of Inflammation and Correlates with Cognition in Stable Schizophrenia. Diagnostics (Basel, Switzerland). vol 10. issue 11. 2020-12-01. PMID:33182582. |
we included 27 patients diagnosed with schizophrenia (f20), after a three-month stable depot antipsychotic therapy (risperidone or paliperidone) and 18 healthy control subjects. |
2020-12-01 |
2023-08-13 |
human |
| Guangfei Li, Xiaowei Han, Wenwen Gao, Zeyu Song, Shuai Zhao, Feiyi Sun, Hong Ma, Ailing Cui, Xiaoying Tang, Guolin M. Influence of EGR3 Transfection on Imaging and Behavior in Rats and Therapeutic Effect of Risperidone in Schizophrenia Model. Frontiers in psychiatry. vol 11. 2020-11-17. PMID:33192626. |
influence of egr3 transfection on imaging and behavior in rats and therapeutic effect of risperidone in schizophrenia model. |
2020-11-17 |
2023-08-13 |
rat |
| Guangfei Li, Xiaowei Han, Wenwen Gao, Zeyu Song, Shuai Zhao, Feiyi Sun, Hong Ma, Ailing Cui, Xiaoying Tang, Guolin M. Influence of EGR3 Transfection on Imaging and Behavior in Rats and Therapeutic Effect of Risperidone in Schizophrenia Model. Frontiers in psychiatry. vol 11. 2020-11-17. PMID:33192626. |
we divided 34 rats into four groups: schizophrenia model group (e group), sham-operation group (fe group), healthy control group (h group), and risperidone therapy group (t group). |
2020-11-17 |
2023-08-13 |
rat |
| Guangfei Li, Xiaowei Han, Wenwen Gao, Zeyu Song, Shuai Zhao, Feiyi Sun, Hong Ma, Ailing Cui, Xiaoying Tang, Guolin M. Influence of EGR3 Transfection on Imaging and Behavior in Rats and Therapeutic Effect of Risperidone in Schizophrenia Model. Frontiers in psychiatry. vol 11. 2020-11-17. PMID:33192626. |
schizophrenia induced several neural alterations in alff and reho metrics of the rat brain, and risperidone could partly reverse these alterations. |
2020-11-17 |
2023-08-13 |
rat |
| Guangfei Li, Xiaowei Han, Wenwen Gao, Zeyu Song, Shuai Zhao, Feiyi Sun, Hong Ma, Ailing Cui, Xiaoying Tang, Guolin M. Influence of EGR3 Transfection on Imaging and Behavior in Rats and Therapeutic Effect of Risperidone in Schizophrenia Model. Frontiers in psychiatry. vol 11. 2020-11-17. PMID:33192626. |
the results suggest that similar research is required for schizophrenia and that risperidone may be a novel treatment for dysregulated neural activation in schizophrenia. |
2020-11-17 |
2023-08-13 |
rat |
| Martin Schaefer, Susanne Sarkar, Ines Theophil, Karolina Leopold, Andreas Heinz, Jürgen Gallina. Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia. Pharmacopsychiatry. vol 53. issue 1. 2020-10-23. PMID:31390660. |
acute and long-term memantine add-on treatment to risperidone improves cognitive dysfunction in patients with acute and chronic schizophrenia. |
2020-10-23 |
2023-08-13 |
Not clear |
| Martin Schaefer, Susanne Sarkar, Ines Theophil, Karolina Leopold, Andreas Heinz, Jürgen Gallina. Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia. Pharmacopsychiatry. vol 53. issue 1. 2020-10-23. PMID:31390660. |
in this proof-of-concept study we tested effects on cognition and negative symptoms of a 6- or 24-week memantine add-on treatment to risperidone in patients with acute or chronic schizophrenia. |
2020-10-23 |
2023-08-13 |
Not clear |
| Atefeh Bamarinejad, Shidrokh Nasiri, Fatemeh Bamarinejad, Rezvan Salehidoost, Elahe Zare-Farashband. Schizophrenia and Macroprolactinoma: Is There a Deep Link? Advanced biomedical research. vol 9. 2020-10-22. PMID:33072650. |
in the present case, we report a 29-year-old single male with schizophrenia who treated for 8 years with risperidone and presented with macroprolactinoma. |
2020-10-22 |
2023-08-13 |
Not clear |